124 related articles for article (PubMed ID: 6511807)
1. Metastatic breast cancer with constantly low CEA blood levels. A subgroup with unfavorable prognosis?
Krieger G; Wander HE; Kneba M; Prangen M; Bandlow G; Nagel GA
J Cancer Res Clin Oncol; 1984; 108(3):341-4. PubMed ID: 6511807
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer.
Loprinzi CL; Tormey DC; Rasmussen P; Falkson G; Davis TE; Falkson HC; Chang AY
J Clin Oncol; 1986 Jan; 4(1):46-56. PubMed ID: 3510282
[TBL] [Abstract][Full Text] [Related]
3. Elevated serum carcinoembryonic antigen and prognosis of breast cancer patients postmastectomy.
Paulick R; Caffier H
Cancer Detect Prev; 1988; 11(3-6):311-7. PubMed ID: 3390852
[TBL] [Abstract][Full Text] [Related]
4. Serial carcinoembryonic antigen (CEA) determinations in the management of patients with breast cancer.
Staab HJ; Ahlemann LM; Koch HL; Anderer FA
Oncodev Biol Med; 1980; 1(3):151-60. PubMed ID: 7279702
[TBL] [Abstract][Full Text] [Related]
5. The role of serum CEA as a prognostic indicator in stage II and III breast cancer patients treated with adjuvant chemotherapy.
Theriault RL; Hortobagyi GN; Fritsche HA; Frye D; Martinez R; Buzdar AU
Cancer; 1989 Mar; 63(5):828-35. PubMed ID: 2914290
[TBL] [Abstract][Full Text] [Related]
6. Serial carcinoembryonic antigen (CEA) determinations in the management of metastatic breast cancer.
Lamerz R; Leonhardt A; Ehrhart H; von Lieven H
Oncodev Biol Med; 1980; 1(2):123-35. PubMed ID: 7279699
[TBL] [Abstract][Full Text] [Related]
7. [Clinical significance of elevated CEA values in the follow-up management of patients with breast cancer].
Paulick R; Caffier H
Geburtshilfe Frauenheilkd; 1985 Nov; 45(11):774-9. PubMed ID: 4076751
[TBL] [Abstract][Full Text] [Related]
8. Prognosis in breast carcinoma utilizing plasma carcinoembryonic antigen and histologic characteristics of the primary tumor.
Bhatavdekar JM; Balar DB; Shah NG; Trivedi SN; Bhaduri A; Patel DD; Karelia NH; Shukla MK; Ghosh N
Tumour Biol; 1987; 8(5):233-40. PubMed ID: 3448770
[TBL] [Abstract][Full Text] [Related]
9. [Determination of the carcinoembryonic antigen (CEA) for predicting the success of therapy in metastatic breast cancer].
Krieger G; Wander HE; Prangen M; Bandlow G; Beyer JH; Nagel GA
Dtsch Med Wochenschr; 1983 Apr; 108(16):610-4. PubMed ID: 6839982
[TBL] [Abstract][Full Text] [Related]
10. Serum carcinoembryonic antigen in the diagnosis and prognosis of women with breast cancer.
Wang DY; Knyba RE; Bulbrook RD; Millis RR; Hayward JL
Eur J Cancer Clin Oncol; 1984 Jan; 20(1):25-31. PubMed ID: 6537913
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen in patients with breast cancer: an adjunctive tool to monitor response and therapy.
Falkson HC; Van Der Watt JJ; Portugal MA; Pitout MJ; Falkson G
Cancer; 1978 Sep; 42(3):1308-13. PubMed ID: 698917
[TBL] [Abstract][Full Text] [Related]
12. [Diagnostic validity of CEA determination in metastasizing breast cancer].
Krieger G; Prangen M; Klar R; Kneba M; Bandlow G; Nagel GA
Klin Wochenschr; 1986 Aug; 64(15):701-7. PubMed ID: 3762017
[TBL] [Abstract][Full Text] [Related]
13. The clinical value of immunohistochemically demonstrable CEA in breast cancer: a possible method of selecting patients for adjuvant chemotherapy.
Smith SR; Howell A; Minawa A; Morrison JM
Br J Cancer; 1982 Nov; 46(5):757-64. PubMed ID: 6756459
[TBL] [Abstract][Full Text] [Related]
14. Biological markers in breast carcinoma. III. Clinical correlations with carcinoembryonic antigen.
Tormey DC; Waalkes TP; Snyder JJ; Simon RM
Cancer; 1977 Jun; 39(6):2397-404. PubMed ID: 872038
[TBL] [Abstract][Full Text] [Related]
15. Sequential carcinoembryonic antigen levels in the therapy of metastatic breast cancer: a predictor and monitor of response and relapse.
Lokich JJ; Zamcheck N; Lowenstein MW
Ann Intern Med; 1978 Dec; 89(6):902-6. PubMed ID: 717986
[TBL] [Abstract][Full Text] [Related]
16. Carcinoembryonic antigen (CEA) in the follow-up of disease-free breast cancer patients.
Veronesi A; Talamini R; Longhi S; Crivellari D; Galligioni E; Tirelli U; Trovò MG; Magri MD; Frustaci S; Figoli F; Zagonel V; Tumolo S; Grigoletto E
Tumori; 1982 Dec; 68(6):477-80. PubMed ID: 7168012
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic value of serum CEA and therapy-induced nonspecific CEA levels in metastasizing breast carcinoma].
Treidler J; Pompecki R; Müllerleile U; Garbrecht M; Kleeberg UR
Onkologie; 1984 Dec; 7(6):328-33. PubMed ID: 6241304
[TBL] [Abstract][Full Text] [Related]
18. [Carcinoembryonic antigens (CEA) in patients with metastatic breast cancer under endocrine and therapeutic treatment (author's transl)].
Pompecki R; Schröder G; Garbrecht M; Frahm H
Dtsch Med Wochenschr; 1978 Apr; 103(14):620-2. PubMed ID: 639696
[TBL] [Abstract][Full Text] [Related]
19. Quantitation of response to therapy in patients with metastatic breast carcinoma by serial analysis of plasma gross cystic disease fluid protein and carcinoembryonic antigen.
Silva JS; Leight GS; Haagensen DE; Tallos PB; Cox EB; Dilley WG; Wells SA
Cancer; 1982 Mar; 49(6):1236-42. PubMed ID: 6174201
[TBL] [Abstract][Full Text] [Related]
20. Is there any clinical relevance of serial determinations of serum carcinoembryonic antigen in small cell lung cancer patients?
Krischke W; Niederle N; Schütte J; Pfeiffer R; Hirche H
Cancer; 1988 Oct; 62(7):1348-54. PubMed ID: 2843279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
